Global Cannabis Applications Corp Exhibits at MJBizCon

Vancouver, British Columbia, Canada, October 14, 2021 – Global Cannabis Applications Corp. ("GCAC" or the "Company") (CSE: APP, FSE: 2FA, OTCQB: FUAPF), a leading medical cannabis chain-of-custody compliance and data platform, announced its exhibit and keynote presentation at MJBizCon in Las Vegas, from October 20-22, 2021.

MJBizCon, an award-winning show, is central to the cannabis industries’ business year. Tens of thousands of business leaders, major private investors, wholesale cultivators, and other professionals attend. GCAC will present GCAC’s Citizen Green Efixii and Prescriptii Patient-Care solutions to over 60,000 conference attendees.

CEO Brad Moore will deliver a keynote address on the MJBizCon LIVE Stage, October 21 at 11 AM. “Beyond Seed to Sale: Using technology to meet compliance and grow sales” will highlight the company’s SaaS solutions for the medical cannabis industry, discussing a better way to build consumer trust, reach sales goals, and maintain strict compliance.

“This marks our entrance to the US market – estimated at $17.5B in 2020 - and present our technologies. Efixii is the first end-to-end blockchain-powered mobile app that seamlessly links medical cannabis cultivators, sellers, and consumers to optimize grow cycle, reduce compliance costs, and improve the customer experience,” says Moore.

With thirty-eight [1] states with legal medical cannabis regimes, the US market is primed for GCAC’s data-driven solutions. And the largest trade show in the industry allows the Company to meet industry leaders face-to-face.

Company executives will hold meetings with cultivators and industry leaders at Booth C2728A.

“Improving product safety in the US market and growing trust in the industry on a state-by-state basis is an important initiative for the Company,” says Moore. “We want to see Efixii QR codes on products across the country, providing safe products transparently to millions of patients.”

Efixii is licensed to cultivators in a SaaS model and is a free-to-use app for cannabis consumers. Efixii’s cannabis efficacy data is the intellectual property (“IP”) of GCAC. This IP creates an inherent difficulty in replicating or competing with GCAC’s cannabis datasets. GCAC defined their protocols in a provisional US patent application, ‘System of Process and Tracking Cannabis Products and Associated Method Using Blockchain’ filed with the USPTO on Dec. 17, 2020.

1.     https://disa.com/map-of-marijuana-legality-by-state

About Global Cannabis Applications Corp. “GCAC”

GCAC is a global leader in designing, developing, SaaS licensing and acquiring innovative data technologies for the medical cannabis industry. The Citizen Green and Efixii platforms are the world's first end-to-end - from patient to regulator - medical cannabis data solutions. They use six core technologies: mobile applications, artificial intelligence, RegTech, smart databases, Ethereum blockchain and GCAC smart rewards. These technologies transparently disclose cannabis chain-of-custody events, thereby enabling patients to provide crowd-sourced medical cannabis efficacy data. Driven by digital and cannabis industry experts, GCAC is focused on generating revenue from SaaS licensing its technology and acquiring high-quality cannabis datasets that improve patient outcomes and to become the world’s largest cannabis efficacy data provider.

For more Company information, please visit www.cannappscorp.com, or review its profiles on www.sedar.com and on the Canadian Securities Exchange's website www.thecse.com.

Press Contact

 Phone: +1 (800) 409-5679

 Email: info@cannappscorp.com

Forward-Looking Information 

This news release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business of GCAC. Forward-looking information is based on certain key expectations and assumptions made by the management of GCAC. Although management of the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because GCAC can give no assurance that they will prove to be correct. Forward-looking statements contained in this news release are made as of the date of this news release. GCAC disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy and accuracy of this information.